# Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

> **NCT05028569** · PHASE3 · TERMINATED · sponsor: **AbbVie** · enrollment: 775 (actual)

## Conditions studied

- Episodic Migraine

## Interventions

- **DRUG:** BOTOX
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05028569
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-05
- **Primary completion:** 2024-11-06
- **Final completion:** 2024-11-06
- **Target enrollment:** 775 (ACTUAL)
- **Why stopped:** The study was terminated early due to lack of efficacy from the primary analysis results.
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05028569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05028569, "Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05028569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*